Dr. Kurian Joseph is an Associate Professor at the department of Oncology, university of Alberta and is a senior Radiation Oncologist at the Cross Cancer Institute, Edmonton, Alberta, Canada. Dr.Joseph had completed his undergraduate medical training at Calicut Medical College, India and did his Radiation Oncology speciality training at the Regional Cancer Centre, Trivandrum, India and at the faculty of Radiology of the Royal College of Surgeons in Ireland. His areas of special interest include cutaneous malignancies, breast oncology and GI-oncology.Professor Michael Veness has been a full-time staff specialist in Radiation Oncology at Westmead hospital, Sydney, since 1998. His clinical practice predominantly involves managing patients with mucosal and cutaneous malignancies of the head and neck. He has had a longstanding clinical research focus on the important and beneficial role of radiotherapy in treating patients with non-melanomaskin cancer and specifically in patients diagnosed with Merkel cell carcinoma (primary cutaneous neuroendocrine malignancy) and high-risk cutaneous squamous cell carcinomas (especially those with metastatic nodes). In addition to a Masters degree in Clinical Epidemiology he has been awarded MDs by published work (both detailing the role of radiotherapy in Merkel cell carcinoma and metastatic nodal SCC, respectively) from both the University of NSW and University of Sydney and has published widely, both locally and internationally, over 160 peer reviewed publications and book chapters on various skin cancer related topics and is a clinical professor with the Sydney Medical School, University of Sydney. He is considered an international expert in this area and believes strongly in educating and informing clinicians managing patients with skin cancer of the often-underappreciated benefits, which in some cases can be lifesaving, to utilising radiotherapy, be that, definitive (i.e. radical), adjuvant (i.e. post op) or palliative radiotherapy.Dr Elizabeth Barnes MD, FRCPC (C) is a radiation oncologist at the Odette Cancer Centre, and associate professor in the department of Radiation Oncology, University of Toronto, Canada. Her clinical and research areas of interest are skin and gynecologic cancer. Prof Agata Rembielak graduated from medicine and medical physics in Poland. She then enrolled in specialist training in radiation oncology in Poland and undertook clinical-research fellowships in Australia, Canada, and UK. She holds research degrees MD and PhD, in both medical sciences and oncology. She has been also a keen medical educator, holding a MA in Medical Education. She works as a Clinical Oncology Consultant at The Christie Hospital in Manchester, UK. In 2023 she has been appointed a MAHSC Honorary Clinical Chair at The University of Manchester, UK. Her research interests include non-melanoma skin cancer, particularly the role of radiotherapy and brachytherapy in skin cancer management, palliative radiotherapy and geriatric oncology. Within ESTRO she is a director at the course “Multidisciplinary management of non-melanoma skin cancer” and leads on the Skin and Soft Tissue Focus Group. She chairs the SIOG Task Force on non-melanoma skin cancer in older adults. Dr Rembielak co-authored UK BAD guidelines on skin SCC and GEC-ESTRO guidelines on skin brachytherapy.
